Logo - springer
Slogan - springer

Medicine - Radiology | EJNMMI Radiopharmacy and Chemistry (Editorial Board)

EJNMMI Radiopharmacy and Chemistry

EJNMMI Radiopharmacy and Chemistry

Editor-in-Chief: Philip H. Elsinga

ISSN: 2365-421X (electronic version)

Journal no. 41181

Editor-in-Chief
Philip H. Elsinga, University Medical Center Groningen, The Netherlands

Associate Editors
Angelika Bischof Delaloye, University of Lausanne, Switzerland
Ignasi Carrio, Autonomous University of Barcelona, Spain

Editorial Board
Mohammed Al-Qahtani, King Faisal Specialist Hospital and Research Center, Saudi Arabia
Martin Behe, Paul Scherrer Institute, Switzerland
Guy Bormans, University of Leuven, Belgium
Giuseppe Carlucci, New York University Langone Health, NY, USA
Jean DaSilva, University of Montral, Canada
Clemens Decristoforo, Medical University Innsbruck, Austria
Mike Kilbourn, University of Michigan Medical School, MI, USA
Klaus Kopka, German Cancer Research Center (DKFZ), Germany
Xiang-Guo Li, Turku PET Centre, Finland
Robert H. Mach, University of Pennsylvania, PN, USA
Oskar Middel, NTNU and St Olavs Hospital, Norway
Jan Passchier, Imperial College London, UK
Marianne Patt, Universität Leipzig, Germany
Ivan Penuelas, University Clinic of Navarra, Spain
Ana Rey, Universidad de la República, Uruguay
Sally Schwarz, Washington University School of Medicine, MO, USA
Sergio Todde, University of Milano-Bicoccia, Italy
Jun Toyohara, Tokyo Metropolitan Institute of Gerontology, Japan
Danielle J Vugts, VU University Medical Center, The Netherlands

Read this journal online

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight in novel concepts of imaging or radionuclide based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in from of guidelines or position papers.

  • Submit Online
  • Instructions for Authors

Alerts for this journal

 

Get the table of contents of every new issue published in EJNMMI Radiopharmacy and Chemistry.